NEW YORK – A group of researchers at the University of Virginia has evaluated Ceres Nanosciences' magnetic capture technology for the isolation of circulating tumor DNA (ctDNA) from other genomic material in blood samples.
NEW YORK – A group of researchers at the University of Virginia has evaluated Ceres Nanosciences' magnetic capture technology for the isolation of circulating tumor DNA (ctDNA) from other genomic material in blood samples.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.